TITLE

Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties

AUTHOR(S)
Shuichi Aoki; Masamichi Mizuma; Yayoi Takahashi; Yoichi Haji; Ryo Okada; Tomoya Abe; Hideaki Karasawa; Keiichi Tamai; Takaho Okada; Takanori Morikawa; Hiroki Hayashi; Kei Nakagawa; Fuyuhiko Motoi; Takeshi Naitoh; Yu Katayose; Michiaki Unno
PUB. DATE
November 2016
SOURCE
BMC Cancer;11/7/2016, Vol. 16, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Little is known about the roles of Notch signaling in cholangiocarcinoma (CC). The expression of hairy and enhancer of split 1 (Hes-1) has not been investigated yet in resected specimens of CC. Notch signaling has been reported to be related to cancer stem cell (CSC) like properties in some malignancies. Our aim is to investigate the participation of Notch signaling in resected specimens of extrahepatic CC (EHCC) and to evaluate the efficacy of CC cells with CSC-like properties by Notch signaling blockade. Methods: First, the expression of Notch1, 2, 3, 4 and Hes-1 was examined by immunohistochemistry in 132 resected EHCC specimens. The clinicopathological characteristics in the expression of Notch receptors and Hes-1 were investigated. Second, GSI IX, which is a γ-secretase-inhibitor, was used for Notch signaling blockade in the following experiment. Alterations of the subpopulation of CD24+CD44+ cells, which are surface markers of CSCs in EHCC, after exposure with GSI IX, gemcitabine (GEM), and the combination of GSI IX plus GEM were assessed by flow cytometry using the human CC cell lines, RBE, HuCCT1 and TFK-1. Also, anchorage-independent growth and mice tumorigenicity in the cells recovered by regular culture media after GSI IX exposure were assessed. Results: Notch1, 2, 3, 4 and Hes-1 in the resected EHCC specimens were expressed in 50.0, 56.1, 42.4, 6.1, and 81.8% of the total cohort, respectively. Notch1 and 3 expressions were associated with poorer histological differentiation (P = 0.008 and 0.053). The patients with the expression of at least any one of Notch1-3 receptors, who were in 80.3% of the total, exhibited poorer survival (P = 0.050). Similarly, the expression of Hes-1 tended to show poor survival (P = 0.093). In all of the examined CC cell lines, GSI IX treatment significantly diminished the subpopulation of CD24+CD44+ cells. Although GEM monotherapy relatively increased the subpopulation of CD24+CD44+ cells in all lines, GSI IX plus GEM attenuated it. Anchorage-independent growth and mice tumorigenicity were inhibited in GSI IX-pretreated cells in RBE and TFK-1 (P < 0.05). Conclusion: Aberrant Notch signaling is involved with EHCC. Inhibition of Notch signaling is a novel therapeutic strategy for targeting cells with CSC-like properties.
ACCESSION #
119315870

 

Related Articles

  • Role of hepatitis B virus X protein in development and progression of primary liver cancer. LIAO Kai; ZHANG Leida // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;2014, Vol. 30 Issue 1, p78 

    Hepatitis B virus (HBV) X protein (HBx) is a multifunctional protein encoded by HBV X gene. It plays a regulatory role in gene transcription, cell signal transduction, cell proliferation and transformation, cell cycle, and cell apoptosis. Currently, HBx is consid-ered to play an important role...

  • Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535. Gedaly, Roberto; Galuppo, Roberto; Daily, Michael F.; Shah, Malay; Maynard, Erin; Chen, Changguo; Zhang, Xiping; Esser, Karyn A.; Cohen, Donald A.; Evers, B. Mark; Jiang, Jieyun; Spear, Brett T. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Activation of the Wnt/β-catenin pathway has been observed in at least 1/3 of hepatocellular carcinomas (HCC), and a significant number of these have mutations in the β-catenin gene. Therefore, effective inhibition of this pathway could provide a novel method to treat HCC. The purposed of...

  • Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma. Kongkavitoon, Pornrat; Tangkijvanich, Pisit; Hirankarn, Nattiya; Palaga, Tanapat // PLoS ONE;1/14/2016, Vol. 11 Issue 1, p1 

    Hepatitis virus B (HBV) infection is one of the major causes of hepatocellular carcinomas (HCC). HBx protein encoded in HBV genome is one of the key viral factors leading to malignant transformation of infected cells. HBx functions by interfering with cellular functions, causing aberration in...

  • Liver Cancer Stem Cells. Mikhail, Sameh; He, Aiwu Ruth // International Journal of Hepatology;2011, p1 

    Hepatocellular carcinoma is the most common primary malignancy of the liver in adults. It is also the fifth most common solid cancer worldwide and the third leading cause of cancer-related death. Recent research supports that liver cancer is a disease of adult stem cells. From the models of...

  • Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma. Yu, Guofeng; Jing, Yingying; Kou, Xingrui; Ye, Fei; Gao, Lu; Fan, Qingmin; Yang, Yang; Zhao, Qiudong; Li, Rong; Wu, Mengchao; Wei, Lixin // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    As the main source of extracellular matrix proteins in tumor stroma, hepatic stellate cells (HSCs) have a great impact on biological behaviors of hepatocellular carcinoma (HCC). In the present study, we have investigated a mechanism whereby HSCs modulate the chemoresistance of hepatoma cells. We...

  • Interaction between gastric cancer stem cells and the tumor microenvironment. Ishimoto, Takatsugu; Sawayama, Hiroshi; Sugihara, Hidetaka; Baba, Hideo // Journal of Gastroenterology;Jul2014, Vol. 49 Issue 7, p1111 

    Gastric cancer (GC) remains a leading cause of cancer-related deaths worldwide. Cancer stem cells (CSCs) are selectively capable of tumor initiation and are implicated in tumor relapse and metastasis, thus, governing the prognosis of GC patients. Stromal cells and extracellular matrix adjacent...

  • Hepatitis C Virus NS3 Protein Can Activate the Notch- Signaling Pathway through Binding to a Transcription Factor, SRCAP. Iwai, Atsushi; Takegami, Tsutomu; Shiozaki, Takuya; Miyazaki, Tadaaki // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Persistent infections of hepatitis C virus (HCV) are known to be a major risk factor for causing hepatocellular carcinomas. Nonstructural protein 3 (NS3) of HCV has serine protease and RNA helicase domains, and is essential for the viral replication. Further, NS3 is also considered to be...

  • Integrative Analysis of Transcriptional Regulatory Network and Copy Number Variation in Intrahepatic Cholangiocarcinoma. Li, Ling; Lian, Baofeng; Li, Chao; Li, Wei; Li, Jing; Zhang, Yuannv; He, Xianghuo; Li, Yixue; Xie, Lu // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Background: Transcriptional regulatory network (TRN) is used to study conditional regulatory relationships between transcriptional factors and genes. However few studies have tried to integrate genomic variation information such as copy number variation (CNV) with TRN to find causal disturbances...

  • UDP?sugar transporter implicated in glycosylation and processing of Notch. Goto, Satoshi; Taniguchi, Misako; Muraoka, Masatoshi; Toyoda, Hidenao; Sado, Yukiko; Kawakita, Masao; Hayashi, Shigeo // Nature Cell Biology;Sep2001, Vol. 3 Issue 9, p816 

    Glycosylation modifies protein activities in various biological processes. Here, we report the functions of a novel UDP?sugar transporter (UST74C, an alternative name for Fringe connection (Frc)) localized to the Golgi apparatus in cellular signalling of Drosophila. Mutants in the frc gene...

  • Notchless encodes a novel WD40-repeat-containing protein that modulates Notch signaling activity. Royet, Julien; Bouwmeester, Tewis; Cohen, Stephen M. // EMBO Journal;12/15/98, Vol. 17 Issue 24, p7351 

    Signaling by Notch family receptors is involved in many cell-fate decisions during development. Several modifiers of Notch activity have been identified, suggesting that regulation of Notch signaling is complex. In a genetic screen for modifiers of Notch activity, we identified a gene encoding a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics